Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Advances in Respiratory Medicine|February 23, 2024
Testing Alpha-1 Antitrypsin Deficiency in Black PopulationsPascale Lafortune, Kanza Zahid, Magdalena Ploszaj, et al.Plos One|October 11, 2023
Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient miceSangmi S Park, Michelle Mai, Magdalena Ploszaj, et al.ERJ Open Research|August 25, 2020
Elevated levels of calpain 14 in nasal tissue in chronic rhinosinusitisMarina Boruk, Abdoulaye J Dabo, Sridesh Nath, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|September 23, 2020
Cigarette smoke induction of S100A9 contributes to chronic obstructive pulmonary diseaseChristopher Railwah, Alnardo Lora, Kanza Zahid, et al.American Journal of Respiratory Cell and Molecular Biology|August 1, 2023
Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for EmphysemaBrian Soto, Huma Ahmed, Meshach Pillai, et al.Biorxiv : the Preprint Server for Biology|May 7, 2026
Dual inhibition of GTP-bound (ON) and GDP-bound (OFF) KRAS G12C suppresses PI3Kα and leads to potent tumor inhibitionKatherine Parker, Samar Ghorbanpoor, Wafa Malik, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinomaAngeliki Karatza, Maayan Pour, Jaylen M Powell, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.Pageof 1